Finally, VP trended to decrease the invasion ability of RA FLS even in pro-inflammatory conditions (Figures 3J, K) and MMP-13 protein level when TNF and IL-17 were co-administered with VP in RA FLS (Figures 3L, M). This evidence concerns the gene MMP13 and rheumatoid arthritis.